凝血辅助腹腔镜瘤内切除术治疗巨大肝血管瘤的安全性与有效性:匹配病例对照研究及文献综述
本研究比较凝血辅助腹腔镜瘤内切除术(LIRC)与腹腔镜肝切除术(LH)治疗巨大肝血管瘤的安全性和有效性。2017至2020年,19例患者接受LIRC,按1:1匹配103例LH患者中的19例。结果显示LIRC组手术时间更短、出血更少、并发症更少、住院更短,临床反应相似。
要点
- LIRC组手术时间相对更短(P<0.001),术中出血更少(P=0.003)。
- 两组术后CRP、TBil、ALT、AST均升高后7天内恢复正常,LIRC组水平相对更低(P<0.05)。
- LIRC组总并发症率相对更低(P=0.029),住院时间更短(P=0.010)。
核心结论
- LIRC治疗巨大肝血管瘤安全有效。
研究设计与样本
- 匹配病例对照研究:2017至2020年,19例巨大肝血管瘤(≥10 cm)患者在一中心接受LIRC。
- 从其他四中心103例接受LH的患者中,按肿瘤位置、肿瘤大小和体重指数1:1匹配19例作为对照组。
主要发现
- 全部38例患者均获得技术成功。
- LIRC组手术时间相对更短(P<0.001),术中出血更少(P=0.003)。
- 术后第1天两组CRP、TBil、ALT、AST均显著升高(P<0.05),7天内恢复正常;LIRC组上述指标血清水平相对更低(P<0.05)。
- LIRC组总并发症率相对低于LH组(P=0.029)。
- LIRC组住院时间短于LH组(P=0.010);两组临床反应相似。
临床怎么用
- 作者认为LIRC治疗巨大肝血管瘤安全有效。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: To report the safety and effectiveness of laparoscopic intratumoral resection facilitated by coagulation (LIRC) compared with laparoscopic hepatectomy (LH) in treating giant hepatic hemangioma. METHODS: From 2017 to 2020, 19 consecutive patients with giant hepatic hemangioma (≥ 10 cm) received LIRC in one center. We selected a subgroup of 103 patients treated by LH in other four centers who well matched the 19 consecutive patients treated with LIRC, in a 1:1 fashion based on the tumor location, tumor size, and body mass index. Furthermore, the differences in technical success, operative time, operative blood loss, change of laboratory indexes, hospital stays, complication and clinical responds are compared between the two groups. RESULTS: Technical success was achieved in all 38 patients. Patients in the LIRC group had a relative shorter operative time (P < 0.001) and less operative blood loss (P = 0.003). The serum levels of C-reactive protein (CRP), total bilirubin (TBil), alanine aminotransferase (ALT), and aspartate transaminase (AST) were elevated significantly (P < 0.05) 1 day after the resection and returned to normal within 7 days in both groups; however, relatively lower serum levels of those indexes were observed in the LIRC group (P < 0.05). The total complication rate was relatively lower in the LIRC group compared with the LH group (P = 0.029). Patients in the LIRC group had shorter hospital stays than those in the LH group (P = 0.010). The clinical response was similar in the two groups. CONCLUSIONS: LIRC is safe and effective for treating giant hepatic hemangioma.
引用
- Wang S, Gao R, Zhao S, et al. Safety and effectiveness of laparoscopic intratumoral resection facilitated by coagulation of giant hepatic hemangioma: a matched case-control study and literature review. Surg Endosc. 2021. PMID: 34845546. doi:10.1007/s00464-021-08891-3
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。